Introduction: Metabolic syndrome (MetS) is a complex and multi-factorial condition that affects millions of people worldwide. Netrin-1 may have an important function in metabolic processes. Aim: There are controversial studies about the role of netrin-1 in MetS. Therefore, the aim of this study was to assess the serum level of netrin-1 and its association with MetS components in our study subjects in this area. Materials and Methods: The National Cholesterol Education Program, Adult Treatment Panel III (NCEP, ATP III) criteria were used to include individuals with MetS. Results: Waist circumference, Systolic blood pressure, diastolic blood pressure, fasting blood glucose (FBG), Triglyceride (TG), High-density lipoprotein cholesterol (HDL-C), and netrin-1 were significantly higher in subjects with MetS than those without MetS (Except HDL-C). FBG and TG were significantly higher in type 2 diabetic patients with MetS than those without MetS (Except HDL-C). Netrin-1 showed a significant positive correlation with FBG in type 2 diabetic patients without MetS. Conclusion: This study may provide that future research should focus on investigating the potential therapeutic role of netrin-1 in the management and prevention of T2DM, and its potential impact on the diagnosis and management of this condition should not be overlooked.
No takes yet. Share an insight, caveat, or question.
Khalil et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: